CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 48:16 Family Friday: Planning for a Safe and Successful Return to School 4 years ago Family Friday,Webinars 57:12 2020 Back-To-School Series: Planning for a Safe and Successful Return to School (August 12, 2020) 4 years ago Care Webinars,COVID-19 Webinars,Webinars 43:30 Family Friday: Do It Your Way & End Duchenne 4 years ago Family Friday,Webinars 15:55 Family Friday: Creating a Unique Virtual Conference Experience 4 years ago Family Friday,Webinars 29:22 Family Friday: When You’re a Carrier 4 years ago Family Friday,Webinars 53:47 Family Friday: Navigating Your Neuromuscular Team 5 years ago Family Friday,Webinars 55:18 Antisense Therapeutics Phase II Trial Final Data Results (June 17, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars 51:01 Family Friday: Advocating for Yourself in Research 5 years ago Family Friday,Webinars «1…910111213…25»Page 11 of 25
by: Parent Project Muscular Dystrophy
